Clinical Chemistry - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Technological advancements in laboratory automation, including point-of-care (POC) testing, and initiatives to increase patient satisfaction are transforming the clinical chemistry market, according to a new report by medical intelligence company GlobalData.

The new report* suggests that rapid growth of POC testing will spread worldwide throughout the coming years, as a result of rising patient and physician satisfaction, increasing awareness of laboratory testing for disease prevention, and increasing disposable income in emerging economies.

Rapid tests and POC testing have become increasingly popular due to impressive doctor and patient satisfaction, which has led to market growth. These testing methods cut down on trips to laboratories, waiting time for results, length of hospital stays, and follow-up appointments with physicians to discuss results. They also have a reduced blood sample requirement for pediatric cases, which improves upon a routine treatment for a huge target market. Studies have shown that, with POC results, physicians are twice as likely to modify or intensify treatments, and are enabled to minimize delays in treatment that could otherwise result in adverse complications.

The increasing number and complexity of tests, coupled with a shortage in laboratory staff, is leading to a greater level of automation in laboratories. Labor accounts for around 65% of operating expenses in a typical laboratory, and automating a laboratory can expand its capabilities while achieving significant savings.

Emerging economies such as India and China are expected to drive the clinical chemistry market in the future. Growing health consciousness among middle and high-income families in India is providing significant business opportunities for preventive healthcare, while in China clinical chemistry boasts support from the government and national institutions. The China National Accreditation Committee for Laboratories (CNACL) exists to support clinical laboratory accreditation, and the Ministry of Health is also preparing additional regulations, indicating both an individual and national concern.

The global market for clinical chemistry was valued at $11.1 billion in 2011, and is forecast to grow at a compound annual growth rate (CAGR) of 6.5%, to reach $17.3 billion in 2018. The US is the largest clinical chemistry market, valued at $4.3 billion in 2011 and expected to reach $6.5 billion in 2018, growing at a CAGR of 6.2% from 2011 to 2018. In contrast, the clinical chemistry markets in China and India were valued at only $702.8 million and $197.5 million respectively in 2011, but are forecast to grow at CAGRs of 17.8% and 19.4% to reach $2,209.7 million and $683.2 million respectively in 2018.

For more information, please visit:

http://www.aarkstore.com/reports/Clinical-Chemistry-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2018-201253.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom